Biotechnology News

July 24, 2012

NEW YORK--(BUSINESS WIRE)--The New York Genome Center (NYGC) and Edward J. Minskoff Equities, Inc. (EJME) are pleased to announce the execution of a 20-year lease for 170,000 square feet at 101 Avenue of the Americas (...

July 24, 2012

SAN JOSE, Calif.--(BUSINESS WIRE)--HTS laboratories continue to adopt new technologies and practices that are leading to more effective drug discovery approaches. For example, the directors at HTS laboratories see an increase in the importance of...

July 24, 2012

CUMBERLAND, R.I.--(BUSINESS WIRE)--Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain is pleased to announce the appointment of Gino Santini to its Board of...

July 24, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) announced today that based upon preliminary financial data the Company expects total second quarter 2012 revenue of approximately $420 million, compared to second quarter 2011...

July 24, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced favorable 52-week safety results and sustained efficacy from the extension phase of its randomized Phase 2b trial of ulodesine (BCX4208)...

July 24, 2012

DUBLIN--(BUSINESS WIRE)--ICON plc, ICON Clinical Research, Ciaran Murray, Brendan Brennan, ICON Quarterly Results

July 24, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will host a conference call and live webcast to report its second quarter 2012 financial results on Tuesday, July 31 at 8:30 a.m. ET. To participate...

July 24, 2012

CINCINNATI--(BUSINESS WIRE)--Camargo Pharmaceutical Services successfully completed five Food and Drug Administration (FDA) pre-IND meetings for 505(b)(2) products , including two of India’s top 10 largest pharma companies.

July 23, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) announced today that Pfizer has issued a top-line result in the first of four Bapineuzumab Phase 3 studies carried out by Pfizer and Janssen AI. The press release can be accessed on...

July 23, 2012

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today announced it has appointed Dr. Mond as its...

July 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Prof. Victor Ambros, whose laboratory identified the first microRNA, joins Firefly BioWorks' Scientific Advisory Board

July 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today launched its real-time PCR reagent portfolio, including a novel, probe-based chemistry for gene expression analysis called NūPCR™. In addition to the NuPCR Reagents, Illumina...

July 23, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that the first subjects have been dosed in a Phase 1, randomized, double-blind, two-period crossover, food effect comparison study of XP23829 in healthy adults....

July 23, 2012

NEW YORK & BARCELONA, Spain--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE:FRX) and Almirall, S.A. (ALM.MC) announced today that the U.S. Food and Drug Administration (FDA) has approved Tudorza™ Pressair™ (aclidinium bromide inhalation...

July 23, 2012

NEW YORK--(BUSINESS WIRE)--WIRED and Robert Wood Johnson Foundation today announced that they are partnering to host the first-ever WIRED Health Conference: Living By Numbers, which will be held on October 15-16, 2012 at Le Parker Meriden in New...

July 23, 2012

NORTHWOOD, Ohio--(BUSINESS WIRE)--NAMSA, the world’s leading medical device research organization, has acquired The Integra Group, a preclinical and clinical research organization located near Minneapolis.

July 23, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--BioPet Vet Lab, has launched IntegriMEAT™, a DNA-source verified program aimed to produce an identification and tracking program for America’s livestock.

July 23, 2012

GENEVA & WASHINGTON & MONTREAL--(BUSINESS WIRE)--Launch of 2 Fields 2 Goal: Protecting the Integrity of Science and Sports campaign to stop doping in sports.

July 23, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/...

July 23, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Nation’s largest bundled payment collaborative helping health systems succeed in public and private market arrangements

July 23, 2012

IRVINE, Calif.--(BUSINESS WIRE)--HALO Healthcare is developing biomarkers for early detection of breast cancer. The kit will use nipple aspirate fluid collected with the HALO Breast Test to detect breast cancer in women.

July 23, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics has received a notice of issuance from the USPTO for key methods of derivation and use for the Company’s carbohydrate-based galectin inhibitor compound in liver fibrosis.

July 23, 2012

NORTH ANDOVER, Mass.--(BUSINESS WIRE)--Aurora Imaging Technology Announces Exclusive China Distribution Agreement With SUMEC Group Corporation

July 23, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the second quarter on Tuesday, July 31, 2012...

July 23, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE MKT: MDGN and MDGN.WS and AIM: MEDG and MEDU), the developer of BiopumpTM, a novel technology for the sustained production and delivery of therapeutic proteins in patients...

July 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV) announced today that it will report financial results for the second quarter ended June 30, 2012 on Tuesday, July 31, 2012. Company management will host a conference call...

July 23, 2012

NEW YORK--(BUSINESS WIRE)--Hyperion Therapeutics' anti-takeover measures could be risk factor for public investors in this week's biotech IPO.

July 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gen9 Sponsors Contest to Recognize Innovation in Synthetic Biology

July 23, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Head-to-Head Study Comparing Navidea’s AZD4694 to the Gold Standard for Imaging Beta Amyloid Protein Deposits Presented at Alzheimer's Association International Conference

July 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the BMO Capital Markets Biotech Corporate Access Day on July 31, 2012, in Boston. In addition, Infinity will be participating in the...

July 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Cancer Index by Mentor Capital (MNTR) is up 29% for 2012 YTD vs 12% for NASDAQ YTD. Immunocellular Therapeutics (IMUC) leads the Index. MNTR is up 372% in 2012 YTD.

July 23, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced the issuance of patents 8,207,233 and 8,207,234 by the U.S. Patent and Trademark...

July 23, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. has retained Australia Biologics Pty. Ltd. as a regulatory consultant to develop a roadmap for human clinical studies of its FluCide(tm) anti-influenza drug candidate in Australia

July 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced that the company has sought leave to file counterclaims against Intelligent Bio-Systems, Inc. (IBS) and Qiagen NV, which recently acquired IBS, in response to the patent...

July 23, 2012

JERUSALEM--(BUSINESS WIRE)--Agriculture relies heavily on the use of pesticides in order to maximise crop yield. However, the widespread use of chemical pesticides has resulted in severe environmental pollution, and many pathogens are developing...

July 23, 2012

AUSTIN, Texas and OKLAHOMA CITY--(BUSINESS WIRE)--Biopharmaceutical company Caisson Biotech's $100 million deal with Novo Nordisk, global diabetes care leader, promoted appointment of biotech veteran Glenn Nedwin, PhD, as new Caisson president...

July 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, today announced that CEO Frank Reynolds is scheduled to...

July 23, 2012

NEW YORK & PETACH TIKVA, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTC:BCLI) announced today that it has completed the planned interim safety review of its Phase I/II ALS (Amyotrophic Lateral Sclerosis) clinical trial, indicating...

July 22, 2012

WASHINGTON--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced final results from the STARTMRK study – the longest double-blind Phase III non-inferiority study evaluating an integrase inhibitor...

July 20, 2012

HENDERSON, Nev. & WESTMINSTER, Colo.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (Spectrum) and Allos Therapeutics, Inc. (NasdaqGS: ALTH) (Allos) today announced that Spectrum has provided an additional extension of the...

July 20, 2012

NORTH HOLLYWOOD, Calif.--(BUSINESS WIRE)--The IMF says today’s Food and Drug Administration approval of Onyx’s Kyprolis (carfilzomib) offers hope to myeloma patients who have run out of options.

July 20, 2012

TIGARD, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (Pink Sheets:BJCT), an innovative developer and manufacturer of needle-free injection therapy systems, today reported unaudited financial results for the year and quarter ended...

July 20, 2012

LAKE ZURICH, Ill. & BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Kabi and Fenwal Inc. announced today a definitive agreement for Fresenius Kabi to acquire Fenwal.

July 20, 2012

WASHINGTON--(BUSINESS WIRE)--Today, Representative Michael Fitzpatrick (R-PA) introduced H.R. 6161, the Fostering Innovation Act, to update SEC filing status classifications for public companies.

July 20, 2012

NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) today announced that its partner, Onyx Pharmaceuticals, Inc., received U.S. Food and Drug Administration (FDA) approval for Kyprolis™ (carfilzomib).

July 20, 2012

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company and Takeda announce postive CHMP opinion for conditional approval of brentuximab vedotin in Europe